Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.
Longo F, Gianesin B, Voi V, Motta I, Pinto VM, Piolatto A, Spasiano A, Ruffo GB, Gamberini MR, Barella S, Mariani R, Fidone C, Rosso R, Casale M, Roberti D, Dal Zotto C, Vitucci A, Bonetti F, Pitrolo L, Quaresima M, Ribersani M, Quota A, Arcioni F, Campisi S, Massa A, De Michele E, Lisi R, Miano M, Bagnato S, Gentile M, Carrai V, Putti MC, Serra M, Gaglioti C, Migone De Amicis M, Graziadei G, De Giovanni A, Ricchi P, Balocco M, Quintino S, Borsellino Z, Fortini M, Denotti AR, Tartaglione I, Beccaria A, Marziali M, Maggio A, Perrotta S, Piperno A, Filosa A, Cappellini MD, De Franceschi L, Piga A, Forni GL. Longo F, et al. Among authors: ruffo gb. Am J Hematol. 2022 Feb 1;97(2):E75-E78. doi: 10.1002/ajh.26429. Epub 2021 Dec 10. Am J Hematol. 2022. PMID: 34861054 Free PMC article. Clinical Trial. No abstract available.
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.
Taher AT, Origa R, Perrotta S, Kourakli A, Ruffo GB, Kattamis A, Goh AS, Cortoos A, Huang V, Weill M, Merino Herranz R, Porter JB. Taher AT, et al. Among authors: ruffo gb. Am J Hematol. 2017 May;92(5):420-428. doi: 10.1002/ajh.24668. Epub 2017 Feb 18. Am J Hematol. 2017. PMID: 28142202 Free PMC article. Clinical Trial.
Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica).
Farruggia P, Puccio G, Ramenghi U, Colombatti R, Corti P, Trizzino A, Barone A, Boscarol G, Ferraro F, Grotto P, Lo Valvo L, Luti L, Matarese SMR, Mosa C, Putti MC, Rubert L, Ruffo GB, Sainati L, Tartaglione I, Russo G, Perrotta S. Farruggia P, et al. Among authors: ruffo gb. Am J Hematol. 2017 Jun;92(6):E103-E105. doi: 10.1002/ajh.24713. Epub 2017 Apr 26. Am J Hematol. 2017. PMID: 28263406 Free article. No abstract available.
Access to emergency departments for acute events and identification of sickle cell disease in refugees.
De Franceschi L, Lux C, Piel FB, Gianesin B, Bonetti F, Casale M, Graziadei G, Lisi R, Pinto V, Putti MC, Rigano P, Rosso R, Russo G, Spadola V, Pulvirenti C, Rizzi M, Mazzi F, Ruffo G, Forni GL. De Franceschi L, et al. Blood. 2019 May 9;133(19):2100-2103. doi: 10.1182/blood-2018-09-876508. Epub 2019 Feb 11. Blood. 2019. PMID: 30745303 Free article. No abstract available.
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
Russo G, De Franceschi L, Colombatti R, Rigano P, Perrotta S, Voi V, Palazzi G, Fidone C, Quota A, Graziadei G, Pietrangelo A, Pinto V, Ruffo GB, Sorrentino F, Venturelli D, Casale M, Ferrara F, Sainati L, Cappellini MD, Piga A, Maggio A, Forni GL. Russo G, et al. Among authors: ruffo gb. Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0. Orphanet J Rare Dis. 2019. PMID: 31146777 Free PMC article. Review.
Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial.
Vitrano A, Ruffo GB, Pepe A, D'Ascola DG, Caruso V, Filosa A, Masera N, Pitrolo L, Rigano P, Cuccia L, Giangreco A, Di Maggio R, Maggio A. Vitrano A, et al. Among authors: ruffo gb. Br J Haematol. 2019 Sep;186(6):e209-e211. doi: 10.1111/bjh.16101. Epub 2019 Jul 25. Br J Haematol. 2019. PMID: 31344255 Free article. Clinical Trial. No abstract available.
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study.
Tartaglione I, Origa R, Kattamis A, Pfeilstöcker M, Gunes S, Crowe S, Fagan N, Vincenzi B, Ruffo GB. Tartaglione I, et al. Among authors: ruffo gb. Exp Hematol Oncol. 2020 Aug 10;9:20. doi: 10.1186/s40164-020-00174-2. eCollection 2020. Exp Hematol Oncol. 2020. PMID: 32793403 Free PMC article.
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds.
Tartaglione I, Manara R, di Concilio R, Quarta A, Ruffo GB, De Michele E, Ammendola F, Foderini MV, Raimo S, Santangelo G, Perrotta S. Tartaglione I, et al. Among authors: ruffo gb. Ann Hematol. 2022 Jan;101(1):241-242. doi: 10.1007/s00277-021-04444-9. Epub 2021 Feb 4. Ann Hematol. 2022. PMID: 33543387 No abstract available.
17 results